Lung Mycobiota α-Diversity Is Linked to Severity in Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

• Published in: Microbiology spectrum Vol. 11; no. 2; p. e0506222
• Main Authors: Enaud, Raphaël, Sioniac, Pierre, Imbert, Sebastien, Janvier, Pierre-Laurent, Camino, Adrian, Bui, Hoang-Nam, Pillet, Odile, Orieux, Arthur, Boyer, Alexandre, Berger, Patrick, Gruson, Didier, Delhaes, Laurence, Prevel, Renaud
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 28.03.2023
• Subjects: Human Microbiome; Research Article; microbiota; severe exacerbation; intensive care unit; mycobiota; chronic obstructive pulmonary disease; human microbiota
• ISSN: 2165-0497; 2165-0497
• DOI: 10.1128/spectrum.05062-22

Chronic obstructive pulmonary disease (COPD) affects more than 200 million people worldwide. The chronic course of COPD is frequently worsened by acute exacerbations (AECOPD). Mortality in patients hospitalized for severe AECOPD remains dramatically high, and the underlying mechanisms are poorly understood. Lung microbiota is associated with COPD outcomes in nonsevere AECOPD, but no study specifically investigated severe AECOPD patients. The aim of this study is thus to compare lung microbiota composition between severe AECOPD survivors and nonsurvivors. Induced sputum or endotracheal aspirate was collected at admission from every consecutive severe AECOPD patient. After DNA extraction, the V3-V4 and ITS2 regions were amplified by PCR. Deep-sequencing was performed on a MiSeq sequencer (Illumina); the data were analyzed using DADA2 pipeline. Among 47 patients admitted for severe AECOPD, 25 (53%) with samples of sufficient quality were included: 21 of 25 (84%) survivors and 4 of 25 (16%) nonsurvivors. AECOPD nonsurvivors had lower α-diversities indices than survivors for lung mycobiota but not for lung bacteriobiota. Similar results were demonstrated comparing patients receiving invasive mechanical ventilation ( = 13 [52%]) with those receiving only noninvasive ventilation ( = 12 [48%]). Previous systemic antimicrobial therapy and long-term inhaled corticosteroid therapy could alter the lung microbiota composition in severe AECOPD patients. In acidemic AECOPD, lower lung mycobiota α-diversity is linked to the severity of the exacerbation, assessed by mortality and the requirement for invasive mechanical ventilation, whereas lung bacteriobiota α-diversity is not. This study encourages a multicenter cohort study investigating the role of lung microbiota, especially fungal kingdom, in severe AECOPD. In AECOPD with acidemia, more severe patients- , nonsurvivors and patients requiring invasive mechanical ventilation-have lower lung mycobiota α-diversity than survivors and patients receiving only noninvasive ventilation, respectively. This study encourages a large multicenter cohort study investigating the role of lung microbiota in severe AECOPD and urges investigation of the role of the fungal kingdom in severe AECOPD.